Jeremy Segal to Administration, Oral
This is a "connection" page, showing publications Jeremy Segal has written about Administration, Oral.
Connection Strength
0.036
-
Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies. Clin Cancer Res. 2019 02 15; 25(4):1174-1184.
Score: 0.036